Enhertu receives CHMP recommendation for adjuvant treatment of HER2-positive early Breast cancer

PADCEV + Keytruda receives positive CHMP opinion for resectable MIBC

SOTIO advances SOT106 with dual FDA designations for Sarcoma

Iza-bren granted BTD in China for the treatment of mTNBC

Telix and ITM join forces to create a radiopharmaceutical powerhouse

BoomRay enters exclusive global license agreement with Novartis for a novel radioligand therapy asset